Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: An observational study from Sri Lanka

BMC Cardiovascular Disorders

Volumn 16, Issue 1, 2016, Pages

  Perera, Nilanka ^a   Indrakumar, Jegarajah ^a   Abeysinghe, Waruni Vijitha ^a   Fernando, Vihangi ^a   Samaraweera, W M C K ^b   Lawrence, Jayamal Sanjaya ^b  

^a UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^b Professorial Surgical Unit   (Sri Lanka)

Author keywords

Acute coronary syndrome; Mortality; Non alcoholic fatty liver disease; Sri Lanka

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GENDER; GRACE SCORE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SRI LANKA; AGED; COMORBIDITY; DYSLIPIDEMIAS; HYPERTENSION; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTER;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SRI LANKA; TERTIARY CARE CENTERS;

EID: 84957888357     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0212-8     Document Type: Article

References (25)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-50.
2. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology. 2003;38:917-23.
3. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16:663-78.
4. World Gastroenterology Organization. WGO Global Guidelines NAFLD/NASH (long version) Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. 2012. 2012.
5. Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24(7):1284-8.
6. Ling S, Shu-zheng LU. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J. 2011;124(6):867-72.
7. Kim D, Choi S, Park EH, Lee W, Kang JH, Kim W, et al. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification. Hepatology. 2012;56:605-13.
8. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 2007;191:391-6.
9. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54:3541-6.
10. Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, La Sala N, et al. Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease. PLoS One. 2014;9(9):e105610. doi: 10.1371/journal.pone.0105610.
11. Choi DH, Lee SJ, Kang CD, Park MO, Choi DW, Kim TS, et al. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013;19(38):6453-7.
12. Arslan U, Kocaǒglu I, Balci M, Duyuler S, Korkmaz A. The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease. J Cardiol. 2012;60(3):210-4. doi: 10.1016/j.jjcc.2012.05.003. Epub 2012 Jun 26.
13. Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, Huang CC, et al. Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease. PLoS One. 2012;7(2):e31799. doi: 10.1371/journal.pone.0031799.
14. Agaç MT, Korkmaz L, Cavusoglu G, Karadeniz AG, Agaç S, Bektas H, et al. Association between non alcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study. Angiology. 2013;64(8):604-8.
15. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13:1579-84.
16. Targher G, Bertolini L, Rodella S, Lippi G, Franchini M, Zoppini G, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring). 2008;16:1394-9.
17. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345-53.
18. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6- month postdischarge death in an international registry. JAMA. 2004;291:2727-33.
19. Bathia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33:1190-2000.
20. Boddi M, Tarquini R, Chiostri M, Marra F, Valente S, Giglioli C, et al. Nonalcoholic fatty liver in non diabetic patients with acute coronary syndromes. Eur J Clin Invest. 2013;43(5):429-38.
21. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis. 2010;42:272-82.
22. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60(12):1721-7.
23. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 2000;35:319-24.
24. Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516-22.
25. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, et al. The role of bright liver echo pattern on ultrasound Bmode examination in the diagnosis of liver steatosis. Dig Liver Dis. 2006;38:485-9.